Simona Luatti

2.2k total citations
24 papers, 788 citations indexed

About

Simona Luatti is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Simona Luatti has authored 24 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 20 papers in Hematology and 14 papers in Rheumatology. Recurrent topics in Simona Luatti's work include Chronic Myeloid Leukemia Treatments (17 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Eosinophilic Disorders and Syndromes (14 papers). Simona Luatti is often cited by papers focused on Chronic Myeloid Leukemia Treatments (17 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Eosinophilic Disorders and Syndromes (14 papers). Simona Luatti collaborates with scholars based in Italy, United States and Switzerland. Simona Luatti's co-authors include Giovanni Martinelli, Nicoletta Testoni, Simona Soverini, Fausto Castagnetti, Giuseppe Saglio, Michele Baccarani, Marilina Amabile, Fabrizio Pane, Francesca Palandri and Gianantonio Rosti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Simona Luatti

24 papers receiving 762 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simona Luatti Italy	12	703	622	444	82	76	24	788
Angela Poerio Italy	8	1.0k 1.5×	886 1.4×	638 1.4×	138 1.7×	75 1.0×	20	1.1k
Lan Beppu United States	11	569 0.8×	405 0.7×	240 0.5×	164 2.0×	59 0.8×	30	625
Alessandra Gnani Italy	7	727 1.0×	597 1.0×	405 0.9×	157 1.9×	64 0.8×	16	788
F-X Mahon France	15	496 0.7×	370 0.6×	230 0.5×	42 0.5×	180 2.4×	26	682
Sabrina Colarossi Italy	9	733 1.0×	606 1.0×	537 1.2×	157 1.9×	71 0.9×	21	1.1k
Michela Rondoni Italy	13	390 0.6×	230 0.4×	156 0.4×	115 1.4×	123 1.6×	42	541
Sara Dellasala United States	11	622 0.9×	388 0.6×	149 0.3×	91 1.1×	207 2.7×	33	695
Wendy T Parker Australia	10	390 0.6×	330 0.5×	170 0.4×	45 0.5×	118 1.6×	22	537
Simona Bassi Italy	8	403 0.6×	451 0.7×	274 0.6×	45 0.5×	30 0.4×	13	625
Angela Volkert United States	6	366 0.5×	313 0.5×	163 0.4×	59 0.7×	69 0.9×	16	480

Countries citing papers authored by Simona Luatti

Since Specialization

Citations

This map shows the geographic impact of Simona Luatti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Luatti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Luatti more than expected).

Fields of papers citing papers by Simona Luatti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Luatti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Luatti. The network helps show where Simona Luatti may publish in the future.

Co-authorship network of co-authors of Simona Luatti

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Luatti. A scholar is included among the top collaborators of Simona Luatti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Luatti. Simona Luatti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baldazzi, Carmen, Simona Luatti, Giulia Marzocchi, et al.. (2021). t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities. Cancer Genetics. 262-263. 35–39. 4 indexed citations

Romano, Marco, Daria Sollazzo, Sara Trabanelli, et al.. (2017). Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis. OncoImmunology. 6(10). e1345402–e1345402. 32 indexed citations

Luatti, Simona, Carmen Baldazzi, Giulia Marzocchi, et al.. (2017). Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy. Oncotarget. 8(18). 29906–29913. 18 indexed citations

Sollazzo, Daria, Dorian Forte, Nicola Polverelli, et al.. (2016). Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly. Mediators of Inflammation. 2016. 1–7. 23 indexed citations

Sollazzo, Daria, Dorian Forte, Nicola Polverelli, et al.. (2016). Crucial factors of the inflammatory microenvironment (IL-1β/TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study. Oncotarget. 7(28). 43974–43988. 19 indexed citations

Baldazzi, Carmen, Simona Luatti, Elisa Zuffa, et al.. (2016). Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities. Genes Chromosomes and Cancer. 55(4). 375–388. 5 indexed citations

Martinelli, Giovanni, Gianantonio Rosti, Michele Baccarani, et al.. (2013). Working Party on CML analysis adverse prognostic influence on frontline imatinib therapy: a GIMEMA Additional chromosomal abnormalities in Philadelphia-positive clone:. 1 indexed citations

Mancini, Manuela, Michela Aluigi, Simona Luatti, et al.. (2013). BCR-ABL1-Associated Reduction of Beta Catenin Antagonist Chibby1 in Chronic Myeloid Leukemia. PLoS ONE. 8(12). e81425–e81425. 14 indexed citations

Soverini, Simona, Alessandra Gnani, Caterina De Benedittis, et al.. (2011). Low-level Bcr–Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib. Leukemia Research. 35(11). 1527–1529. 4 indexed citations

10.

Castagnetti, Fausto, Nicoletta Testoni, Simona Luatti, et al.. (2010). Deletions of the Derivative Chromosome 9 Do Not Influence the Response and the Outcome of Chronic Myeloid Leukemia in Early Chronic Phase Treated With Imatinib Mesylate: GIMEMA CML Working Party Analysis. Journal of Clinical Oncology. 28(16). 2748–2754. 33 indexed citations

11.

Colarossi, Sabrina, Alessandra Gnani, Simona Soverini, et al.. (2009). GENOME-WIDE SCREENING OF CHRONIC MYELOID LEUKEMIA PATIENTS BY SNP ARRAYS: ALTERATIONS ASSOCIATED WITH DISEASE PROGRESSION. Haematologica. 94. 19–19. 2 indexed citations

12.

Palandri, Francesca, Fabio Castagnetti, Simona Soverini, et al.. (2009). Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure. Haematologica. 94(12). 1758–1761. 26 indexed citations

13.

Castagnetti, Fausto, Francesca Palandri, Marilina Amabile, et al.. (2009). Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party. Blood. 113(15). 3428–3434. 53 indexed citations

14.

Soverini, Simona, Sabrina Colarossi, Alessandra Gnani, et al.. (2009). High-Resolution Genome Wide Copy Number Alteration (CNA) and Loss of Heterozigosity (LOH) Analysis in Chronic Myeloid Leukemia (CML) Shows That High and Intermediate Sokal Risk Pts (Pts) Have Multiple Losses Targeting Genes Involved in DNA Repair.. Blood. 114(22). 3262–3262. 2 indexed citations

15.

Palandri, Francesca, Fausto Castagnetti, G. Alimena, et al.. (2009). The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up. Haematologica. 94(2). 205–212. 57 indexed citations

16.

Terragna, Carolina, Sandra Durante, Annalisa Astolfi, et al.. (2008). Gene Expression Profile (GEP) of Chronic Myeloid Leukemia (CML) Patients at Diagnosis: Two Distinguished Subgroups of CML Patients Identified, Based on a Molecular Signature, Irrespective of Their Sokal Risk Score. Blood. 112(11). 3190–3190. 4 indexed citations

17.

Soverini, Simona, Sabrina Colarossi, Alessandra Gnani, et al.. (2007). Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain. Haematologica. 92(3). 401–404. 133 indexed citations

18.

Soverini, Simona, Giovanni Martinelli, Sabrina Colarossi, et al.. (2006). Mutations at Residues 315 and 317 in the ABL Kinase Domain Are the Main Cause of Resistance to Dasatinib in Philadelphia-Positive (Ph+) Leukemia Patients (pts).. Blood. 108(11). 836–836. 6 indexed citations

19.

Rosti, Gianantonio, Giovanni Martinelli, Simona Bassi, et al.. (2003). Molecular response to imatinib in late chronic-phase chronic myeloid leukemia. Blood. 103(6). 2284–2290. 56 indexed citations

20.

Catani, Lucia, Nicola Vianelli, Simona Luatti, et al.. (1999). Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets. Bone Marrow Transplantation. 24(11). 1191–1194. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact